ABC294640
Showing 1 - 9 of 9
Cholangiocarcinoma, Cholangiocarcinoma Non-resectable, Cholangiocarcinoma, Perihilar Trial (ABC294640)
Available
- Cholangiocarcinoma
- +4 more
- ABC294640
- (no location specified)
Mar 14, 2022
Multiple Myeloma Trial in Durham (Opaganib)
Terminated
- Multiple Myeloma
-
Durham, North CarolinaDuke University Medical Center
May 24, 2021
Coronavirus Infections Trial in Israel, United States (Opaganib, Placebo)
Pancreatic Cancer, Solid Tumor Trial in Charleston (sphingosine kinase-2 inhibitor ABC294640)
Completed
- Pancreatic Cancer
- Unspecified Adult Solid Tumor, Protocol Specific
- sphingosine kinase-2 inhibitor ABC294640
-
Charleston, South CarolinaMedical University of South Carolina
Jan 4, 2020
Opaganib in Patients With Coronavirus Disease 2019 (COVID-19)
Completed
- Coronavirus Infections
- Opaganib
- Standard of Care
-
Jerusalem, IsraelShaare-Zedek Medical Center
Jun 16, 2020
Carcinoma, Hepatocellular Trial in Charleston (ABC294640)
Withdrawn
- Carcinoma, Hepatocellular
- ABC294640
-
Charleston, South CarolinaMedical University of South Carolina
Sep 10, 2019
Diffuse Large B Cell Lymphoma, Kaposi Sarcoma Trial in New Orleans (ABC294640)
Withdrawn
- Diffuse Large B Cell Lymphoma
- Kaposi Sarcoma
- ABC294640
-
New Orleans, LouisianaLouisiana State University Health Sciences Center
Dec 5, 2017